Menthol

Menthol

SCHEMBL3817833

CC1CCC(C(C)C)C(O)C1.CC1CCC(C(C)C)C(OC(=O)C(C)O)C1

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

TRPA1TRPM8

The experimentally established mechanism targets of Menthol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TRPA1 known ✓ O75762 2/20 0.60
TRPM8 known ✓ Q7Z2W7 2/20 0.60
EPHX1 P07099 3/20 0.51
ALDH1A1 P00352 7/20 0.47
HPGD P15428 2/20 0.47
CYP19A1 P11511 2/20 0.46
MAPT P10636 3/20 0.43
TSHR P16473 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
KDM4E B2RXH2 1/20 0.42
GAA P10253 1/20 0.42
MAPK1 P28482 1/20 0.42
LMNA P02545 2/20 0.41
USP2 O75604 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7636456 0.93 EPHX1 (0.57) TRPA1TRPM8EPHX1ALDH1A1HPGD
SCHEMBL12522387 0.93 EPHX1 (0.57) TRPA1TRPM8EPHX1ALDH1A1HPGD
SCHEMBL15291348 0.93 EPHX1 (0.57) TRPA1TRPM8EPHX1ALDH1A1HPGD
SCHEMBL12449351 0.93 EPHX1 (0.57) TRPA1TRPM8EPHX1ALDH1A1HPGD
SCHEMBL471089 0.93 EPHX1 (0.57) TRPA1TRPM8EPHX1ALDH1A1HPGD
SCHEMBL23196361 0.93 EPHX1 (0.57) TRPA1TRPM8EPHX1ALDH1A1HPGD
SCHEMBL13430521 0.93 EPHX1 (0.57) TRPA1TRPM8EPHX1ALDH1A1HPGD
SCHEMBL12449339 0.93 EPHX1 (0.57) TRPA1TRPM8EPHX1ALDH1A1HPGD
SCHEMBL320044 0.93 EPHX1 (0.57) TRPA1TRPM8EPHX1ALDH1A1HPGD
SCHEMBL15697973 0.93 EPHX1 (0.57) TRPA1TRPM8EPHX1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10835610-B2 Pharmaceutical or cosmetic compositions comprising a polymer and an absorption promoter for controlled release of active ingredients EMENEM s.r.l. (IT) 2020-11-17 US claimed
US-20170239357-A1 PHARMACEUTICAL OR COSMETIC COMPOSITIONS COMPRISING A POLYMER AND AN ABSORPTION PROMOTER FOR CONTROLLED RELEASE OF ACTIVE INGREDIENTS EMENEM s.r.l. (IT) 2017-08-24 US claimed
CN-104812732-A Composition of menthol and menthyl lactate, its preparation and its use as a cooling, flavouring and/or fragrance agent BASF SE 2015-07-29 CN claimed
EP-1146852-B1 A COSMETIC COMPOSITION BASED ON MENTHOL AND MENTHYL LACTATE, HAVING LITTLE ODOR AND BEING NON-IRRITATING JOHNSON & JOHNSON CONSUMER FR (FR) 2003-04-02 EP claimed
US-20020119110-A1 For use as shower gel, foaming gel for face JOHNSON & JOHNSON CONSUMER FRANCE SAS, ROC DIVISION (FR) 2002-08-29 US claimed
CN-1337874-A Cosmetic composition based on menthol and menthyl lactate, without odour and without irritation JOHNSON & JOHNSON CONSUMER FR (FR) 2002-02-27 CN claimed
EP-1146852-A1 A COSMETIC COMPOSITION BASED ON MENTHOL AND MENTHYL LACTATE, HAVING LITTLE ODOR AND BEING NON-IRRITATING Johnson & Johnson Consumer France (FR) 2001-10-24 EP claimed
WO-2000042983-A1 A COSMETIC COMPOSITION BASED ON MENTHOL AND MENTHYL LACTATE, HAVING LITTLE ODOR AND BEING NON-IRRITATING JOHNSON & JOHNSON CONSUMER FRANCE (FR) 2000-07-27 WO claimed
US-12478942-B2 Methods of making capsules THE PROCTER & GAMBLE COMPANY (US) 2025-11-25 US disclosed
EP-3955890-B1 CAPSULES PROCTER & GAMBLE (US) 2025-07-16 EP disclosed
US-12343696-B2 Capsules THE PROCTER & GAMBLE COMPANY (US) 2025-07-01 US disclosed
CN-113660926-B capsule 宝洁公司 2025-03-07 CN disclosed
US-20240238748-A1 CAPSULES PROCTER & GAMBLE (US) 2024-07-18 US disclosed
US-11904287-B2 Capsules THE PROCTER & GAMBLE COMPANY (US) 2024-02-20 US disclosed
CN-1337874-A Cosmetic composition based on menthol and menthyl lactate, without odour and without irritation JOHNSON & JOHNSON CONSUMER FR (FR) 2002-02-27 CN disclosed
CN-1337874-A Cosmetic composition based on menthol and menthyl lactate, without odour and without irritation JOHNSON & JOHNSON CONSUMER FR (FR) 2002-02-27 CN disclosed
EP-1146852-A1 A COSMETIC COMPOSITION BASED ON MENTHOL AND MENTHYL LACTATE, HAVING LITTLE ODOR AND BEING NON-IRRITATING Johnson & Johnson Consumer France (FR) 2001-10-24 EP disclosed
EP-1146852-A1 A COSMETIC COMPOSITION BASED ON MENTHOL AND MENTHYL LACTATE, HAVING LITTLE ODOR AND BEING NON-IRRITATING Johnson & Johnson Consumer France (FR) 2001-10-24 EP disclosed
WO-2000042983-A1 A COSMETIC COMPOSITION BASED ON MENTHOL AND MENTHYL LACTATE, HAVING LITTLE ODOR AND BEING NON-IRRITATING JOHNSON & JOHNSON CONSUMER FRANCE (FR) 2000-07-27 WO disclosed
WO-2000042983-A1 A COSMETIC COMPOSITION BASED ON MENTHOL AND MENTHYL LACTATE, HAVING LITTLE ODOR AND BEING NON-IRRITATING JOHNSON & JOHNSON CONSUMER FRANCE (FR) 2000-07-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10835610-B2 Pharmaceutical or cosmetic compositions comprising a polymer and an absorption promoter for controlled release of active ingredients LIPA, MITF, CUTA TRPA1 490/4885TRPM8 198/4885EPHX1 3372/4885
US-20170239357-A1 PHARMACEUTICAL OR COSMETIC COMPOSITIONS COMPRISING A POLYMER AND AN ABSORPTION PROMOTER FOR CONTROLLED RELEASE OF ACTIVE INGREDIENTS LIPA, MITF, CUTA TRPA1 490/4885TRPM8 198/4885EPHX1 3372/4885
US-20020119110-A1 For use as shower gel, foaming gel for face LDHA, LDHB, ADH5 TRPA1 192/4885TRPM8 28/4885EPHX1 1029/4885
US-12478942-B2 Methods of making capsules FUT6, FUT5, LIPA TRPA1 4829/4885TRPM8 4570/4885EPHX1 2355/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.